Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.
Shima H, Kutomi G, Satomi F, Imamura M, Kimura Y, Mizuguchi T, Watanabe K, Takahashi A, Murai A, Tsukahara T, Kanaseki T, Hirohashi Y, Iwayama Y, Tsuruma T, Kameshima H, Sato N, Torigoe T, Takemasa I. Shima H, et al. Among authors: iwayama y. Cancer Immunol Immunother. 2018 Oct;67(10):1603-1609. doi: 10.1007/s00262-018-2217-x. Epub 2018 Aug 1. Cancer Immunol Immunother. 2018. PMID: 30069687 Free PMC article.
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.
Tsuruma T, Iwayama Y, Ohmura T, Katsuramaki T, Hata F, Furuhata T, Yamaguchi K, Kimura Y, Torigoe T, Toyota N, Yagihashi A, Hirohashi Y, Asanuma H, Shimozawa K, Okazaki M, Mizushima Y, Nomura N, Sato N, Hirata K. Tsuruma T, et al. Among authors: iwayama y. J Transl Med. 2008 May 10;6:24. doi: 10.1186/1479-5876-6-24. J Transl Med. 2008. PMID: 18471305 Free PMC article. Clinical Trial.
Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients.
Kameshima H, Tsuruma T, Torigoe T, Takahashi A, Hirohashi Y, Tamura Y, Tsukahara T, Ichimiya S, Kanaseki T, Iwayama Y, Sato N, Hirata K. Kameshima H, et al. Among authors: iwayama y. Cancer Sci. 2011 Jun;102(6):1181-7. doi: 10.1111/j.1349-7006.2011.01918.x. Epub 2011 Apr 24. Cancer Sci. 2011. PMID: 21371173 Free article. Clinical Trial.
Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients.
Kameshima H, Tsuruma T, Kutomi G, Shima H, Iwayama Y, Kimura Y, Imamura M, Torigoe T, Takahashi A, Hirohashi Y, Tamura Y, Tsukahara T, Kanaseki T, Sato N, Hirata K. Kameshima H, et al. Among authors: iwayama y. Cancer Sci. 2013 Jan;104(1):124-9. doi: 10.1111/cas.12046. Epub 2012 Dec 16. Cancer Sci. 2013. PMID: 23078230 Free PMC article. Clinical Trial.
Treatment with beta-SQAG9 prevents rat hepatic ischemia-reperfusion injury.
Shima H, Tsuruma T, Sahara H, Takenouchi M, Takahashi N, Iwayama Y, Yagihashi A, Watanabe N, Sato N, Hirata K. Shima H, et al. Among authors: iwayama y. Transplant Proc. 2005 Jan-Feb;37(1):417-21. doi: 10.1016/j.transproceed.2004.12.240. Transplant Proc. 2005. PMID: 15808663
Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats.
Tsuruma T, Sahara H, Takenouchi M, Yagihashi A, Iwayama Y, Shima H, Furuhata T, Torigoe T, Hanashima S, Yamazaki T, Sugawara F, Mizushina Y, Ohta K, Sakaguchi K, Sato N, Hirata K. Tsuruma T, et al. Among authors: iwayama y. Transplant Proc. 2004 Sep;36(7):1965-9. doi: 10.1016/j.transproceed.2004.08.089. Transplant Proc. 2004. PMID: 15518713
198 results